Rapt TherapeuticsRAPT
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 62 institutions reported holding Rapt Therapeutics Inc. (RAPT) in their 13F filings, up 14 from Q2 2025. 23 opened new positions and 9 sold out. The largest holders were TCG Crossover Management, LLC ($42.2M), Foresite Capital Management VI LLC ($40.3M) and RTW Investments, LP ($37.9M). 4 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Rapt Therapeutics Inc.
- CUSIP
- 75382E208
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 23 | $84.5M |
| Exits | 9 | $31.8M |
All 13F filers, Q2 2025 → Q3 2025: 3,641,318 shares bought and 5,638,001 shares sold, net −1,996,683 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 62 holders
| TCG Crossover Management, LLC | 2.08% | No change | 1,636,275 | $42.2M |
| Foresite Capital Management VI LLC | 15.57% | No change | 1,562,500 | $40.3M |
| RTW Investments, LP | 0.47% | No change | 1,470,499 | $37.9M |
| Orbimed Advisors LLC | 0.67% | Reduce -33.8% | 1,086,618 | $28.0M |
| Boone Capital Management LLC | 6.62% | New | 782,461 | $20.2M |
| Deep Track Capital, LP | 0.54% | No change | 751,422 | $19.4M |
| Vanguard Group Inc. | 0.00% | Reduce -20.9% | 696,188 | $18.0M |
| Nantahala Capital Management, LLC | 0.99% | Reduce -34.5% | 623,282 | $16.1M |
| Ikarian Capital, LLC | 3.21% | New | 615,000 | $15.9M |
| Siren, L.L.C. | 0.59% | New | 580,466 | $15.0M |
| Redmile Group, LLC | 1.39% | Reduce -12.4% | 552,594 | $14.3M |
| Soleus Capital Management, L.P. | 0.74% | New | 537,903 | $13.9M |
| ADAR1 Capital Management, LLC | 1.31% | Reduce -35.2% | 507,771 | $13.1M |
| FCPM III Services B.V. | 1.77% | Reduce -21.8% | 344,237 | $8.9M |
| FMR LLC | 0.00% | Add +12729.4% | 248,378 | $6.4M |
| Boothbay Fund Management, LLC | 0.15% | New | 223,860 | $5.8M |
| Perceptive Advisors LLC | 0.14% | No change | 183,890 | $4.7M |
| Invesco Ltd. | 0.00% | New | 140,544 | $3.6M |
| Geode Capital Management, LLC | 0.00% | Reduce -13.3% | 121,464 | $3.1M |
| SummitTX Capital, L.P. | 0.10% | New | 91,912 | $2.4M |
| BlackRock, Inc. | 0.00% | Reduce -0.4% | 89,503 | $2.3M |
| Euclidean Capital LLC | 0.89% | No change | 82,234 | $2.1M |
| Velan Capital Investment Management LP | 1.94% | New | 79,977 | $2.1M |
| Goldman Sachs Group Inc. | 0.00% | Add +176.6% | 61,576 | $1.6M |
| Ameriprise Financial Inc. | 0.00% | New | 51,406 | $1.3M |
| Balyasny Asset Management L.P. | 0.00% | New | 50,348 | $1.3M |
| Susquehanna International Group, LLP | 0.00% | New | 45,382 | $1.2M |
| Millennium Management | 0.00% | Add +75.2% | 39,278 | $1.0M |
| State Street Corp. | 0.00% | Add +96.1% | 37,383 | $964K |
| Two Sigma Investments, LP | 0.00% | Reduce -20.2% | 34,818 | $898K |
| Superstring Capital Management LP | 0.88% | Add +32.3% | 34,449 | $888K |
| Renaissance Technologies | 0.00% | Reduce -45.1% | 34,311 | $885K |
| UBS Group AG | 0.00% | Add +680.3% | 28,808 | $743K |
| Morgan Stanley | 0.00% | Add +22.7% | 22,096 | $570K |
| Bridgeway Capital Management, LLC | 0.01% | Add +32.0% | 20,625 | $532K |
| Northern Trust Corp. | 0.00% | Reduce -31.2% | 17,020 | $439K |
| Marshall Wace, LLP | 0.00% | New | 16,845 | $434K |
| Acadian Asset Management LLC | 0.00% | Reduce -81.6% | 16,788 | $432K |
| Citadel Advisors | 0.00% | New | 15,530 | $401K |
| Royal Bank of Canada | 0.00% | Add +0.1% | 14,454 | $373K |
| HighTower Advisors, LLC | 0.00% | New | 12,625 | $326K |
| Point72 Asset Management | 0.00% | New | 12,378 | $319K |
| Gsa Capital Partners LLP | 0.02% | Reduce -13.1% | 10,558 | $272K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 10,000 | $258K |
| Trustees of Columbia University in the City of New York | 0.04% | New | 9,172 | $237K |
| Dimensional Fund Advisors LP | 0.00% | New | 8,934 | $231K |
| Bank of America Corp. | 0.00% | Reduce -42.6% | 3,971 | $102K |
| Group One Trading LLC | 0.00% | New | 2,699 | $70K |
| Russell Investments Group, Ltd. | 0.00% | No change | 1,080 | $28K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 497 | $13K |
| JPMorgan Chase & Co. | 0.00% | Reduce -0.3% | 323 | $8K |
| Banque Cantonale Vaudoise | 0.00% | New | 154 | $7K |
| Cwm, LLC | 0.00% | Reduce -83.9% | 113 | $3K |
| Barclays PLC | 0.00% | Add +331.8% | 95 | $2K |
| Nisa Investment Advisors, LLC | 0.00% | No change | 79 | $2K |
| BNP Paribas Financial Markets | 0.00% | Reduce -41.5% | 79 | $2K |
| Fortitude Family Office, LLC | 0.00% | New | 63 | $2K |
| EverSource Wealth Advisors, LLC | 0.00% | Add +3.6% | 58 | $1K |
| Citigroup Inc. | 0.00% | Reduce -98.9% | 24 | $619 |
| Point72 (DIFC) Ltd | 0.00% | New | 16 | $405 |
| Arax Advisory Partners | 0.00% | New | 1 | $25 |
| Bessemer Group Inc. | 0.00% | New | 11 | $0 |
"% of holder's portfolio" is RAPT's weight in each manager's 13F, not the share of Rapt Therapeutics Inc. the manager owns.